Investor Relations


Scroll
Announcements

All

2022
2023
2024
2025
  • 2025.12.15 SUPPLEMENTAL ANNOUNCEMENT REGARDING CANCELLATION OF BOOK CLOSURE PERIOD
  • 2025.12.12 PROXY FORM FOR THE 2025 THIRD EXTRAORDINARY GENERAL MEETING TO BE HELD ON DECEMBER 30, 2025
  • 2025.12.12 NOTICE OF THE 2025 THIRD EXTRAORDINARY GENERAL MEETING
  • 2025.12.12 (1) PROPOSED ABOLISHMENT OF THE BOARD OF SUPERVISORS; (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; (3) PROPOSED AMENDMENTS TO THE RULES OF PROCEDURE FOR SHAREHOLDERS' MEETINGS; (4) PROPOSED AMENDMENTS TO THE RULES OF PROCEDURE FOR THE BOARD OF DIRECTORS; AND (5) NOTICE OF THE 2025 THIRD EXTRAORDINARY GENERAL MEETING
  • 2025.12.12 (1) PROPOSED ABOLISHMENT OF THE BOARD OF SUPERVISORS; (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; (3) PROPOSED AMENDMENTS TO THE RULES OF PROCEDURE FOR SHAREHOLDERS' MEETINGS; (4) PROPOSED AMENDMENTS TO THE RULES OF PROCEDURE FOR THE BOARD OF DIRECTORS
  • 2025.12.08 ANNOUNCEMENT - BOOK CLOSURE PERIOD FOR THE 2025 THIRD EXTRAORDINARY GENERAL MEETING
  • 2025.12.04 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
  • 2025.11.20 VOLUNTARY ANNOUNCEMENT THE SIX-MONTH CLINICAL FOLLOW-UP RESULTS FOR LARGE ANNULUS PATIENTS OF LUX-VALVE PLUS TRINITY STUDY AND CLINICAL APPLICATION RESULTS FOR LARGE ANNULUS PATIENTS OF KEN-VALVE RELEASED AT PCR LONDON VALVES 2025, DEMONSTRATING LARGE SIZE ADVANTAGES WITH PRODUCT UNIQUENESS
  • 2025.11.06 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
  • 2025.10.31 CLARIFICATION ANNOUNCEMENT